Updated Molecular Spectrum of β-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration

References

• Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11.
   PubMed Web of Science ®Google Scholar
• Al-Allawi N, Al Allawi S, Jalal SD. Genetic epidemiology of hemoglobinopathies among Iraqi Kurds. J Community Genet. 2021;12(1):5–14.
   PubMed Web of Science ®Google Scholar
• Thalassemia Research Network. Interactive database for hemoglobin variants (ITHANET). Ithagene database. Available from: http://ithanet.eu/db/ithagenes.
   Google Scholar
• Weatherall DJ, Clegg JB. The thalassaemia syndromes. 4th edition. Oxford (Oxfordshire, UK): Blackwell Scientific Publications; 2001.
   Google Scholar
• Musallam KM, Taher AT, Rachmilewitz EA. β-Thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med. 2012;2(7):a013482.
   PubMed Web of Science ®Google Scholar
• Galanello R, Cao A. Relationship between genotype and phenotype. Thalassemia intermedia. Ann N Y Acad Sci. 1998;850:325–333.
   PubMed Web of Science ®Google Scholar
• United Nations High Commissioner for Refugees. Displacement as a challenge and opportunity – urban profile: refugees, internally displaced persons and host community, Duhok Governate, Kurdistan region of Iraq. Aug 2016. Available from: http://data2.unchr.org/en/documents/download/52297.
   Google Scholar
• Al-Allawi NAS, Jubrael JMS, Hughson M. Molecular characterization of β-thalassemia in the Dohuk region of Iraq. Hemoglobin. 2006;30(4):479–486.
   PubMed Web of Science ®Google Scholar
• Al-Allawi NAS, Hassan KMA, Sheikha AK, et al. β-Thalassemia mutations among transfusion-dependent thalassemia major patients in northern Iraq. Mol Biol Int. 2010;2010:479282.
   PubMedGoogle Scholar
• Modell B, Khan M, Darlison M. Survival in beta-thalassaemia major in the UK: data from the UK thalassaemia register. Lancet. 2000;355(9220):2051–2052.
   PubMed Web of Science ®Google Scholar
• Thuret I, Pondarré C, Loundou A, et al. Complications and treatment of patients with β-thalassemia in France: results of the National Registry. Haematologica. 2010;95(5):724–729.
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Cohen A, Porter J, editors, et al.. Guidelines for the management of transfusion dependent thalassemia (TDT). 3rd ed. Nicosia (Cyprus): Thalassemia International Federation; 2014.
   Google Scholar
• Atroshi SD, Al-Allawi N, Chui DHK, et al. A novel β0-thalassemia mutation, HBB: c.356_357delTT [codon 118 (-TT)] in an Iraqi Kurd. Hemoglobin. 2021;45(3):212–213.
   PubMed Web of Science ®Google Scholar
• Giardine BM, Joly P, Pissard S, et al. Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2021;49(D1):D1192–D1196.
   PubMed Web of Science ®Google Scholar
• Kattamis A, Forni GL, Aydinok Y, et al. Changing patterns in the epidemiology of β-thalassemia. Eur J Haematol. 2020;105(6):692–703.
   PubMed Web of Science ®Google Scholar
• Eissa AA, Kashmoola MA, Atroshi SD, Al-Allawi NAS. Molecular characterization of β-thalassemia in Nineveh Province illustrates the relative heterogeneity of mutation distributions in Northern Iraq. Indian J Hematol Blood Transfus. 2015;31(2):213–217.
   PubMed Web of Science ®Google Scholar
• Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The beta-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001;25(3):285–296.
   PubMed Web of Science ®Google Scholar
• Derakhshandeh-Peykar P, Akhavan-Niaki H, Tamaddoni A, et al. Distribution of β-thalassemia mutations in the northern provinces of Iran. Hemoglobin. 2007;31(3):351–356.
   PubMed Web of Science ®Google Scholar
• Akhavan-Niaki H, Derakhshandeh-Peykar P, Banihashemi A, et al. A comprehensive molecular characterization of beta thalassemia in a highly heterogeneous population. Blood Cells Mol Dis. 2011;47(1):29–32.
   PubMed Web of Science ®Google Scholar
• Amin S, Jalal S, Ali K, et al. Molecular characterization and disease-related morbidities of β-thalassemia patients from the northeastern part of Iraq. Int J Gen Med. 2020;13:1453–1467.
   PubMed Web of Science ®Google Scholar
• Haghi M, Khorshidi S, Hosseinpour Feizi MA, et al. β-Thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces. Hemoglobin. 2009;33(2):109–114.
   PubMed Web of Science ®Google Scholar
• Jalal SD, Al-Allawi NAS, Bayat N, et al. β-Thalassemia mutations in the Kurdish population of Northeastern Iraq. Hemoglobin. 2010;34(5):469–476.
   PubMed Web of Science ®Google Scholar
• Rahimi Z, Muniz A, Akramipour R, et al. Haplotype analysis of beta thalassemia patients in Western Iran. Blood Cells Mol Dis. 2009;42(2):140–143.
   PubMed Web of Science ®Google Scholar
• Tadmouri GO, Tüzmen S, Ozçelik H, et al. Molecular and population genetic analyses of beta-thalassemia in Turkey. Am J Hematol. 1998;57(3):215–220.
   PubMed Web of Science ®Google Scholar
• El-Latif MA, Filon D, Rund D, et al. The β+-IVS-I-6 (T→C) mutation accounts for half of the thalassemia chromosomes in the Palestinian populations of the mountain regions. Hemoglobin. 2002;26(1):33–40.
   PubMed Web of Science ®Google Scholar
• El-Gawhary S, El-Shafie S, Niazi M, et al. Study of β-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients. Hemoglobin. 2007;31(1):63–69.
   PubMed Web of Science ®Google Scholar
• Makhoul NJ, Wells RS, Kaspar H, et al. Genetic heterogeneity of β-thalassemia in Lebanon reflects historic and recent population migration. Ann Hum Genet. 2005;69(Pt 1):55–66.
   PubMed Web of Science ®Google Scholar
• Filon D, Oron V, Shawa R, et al. Spectrum of β-thalassemia mutations in the Gaza area. Hum Mutat. 1995;5(4):351–353.
   PubMed Web of Science ®Google Scholar
• Murad H, Moasses F, Dabboul A, et al. Geographical distribution of β-globin gene mutations in Syria. Hematology. 2018;23(9):697–704.
   PubMed Web of Science ®Google Scholar
• Rund D, Cohen T, Filon D, et al. Evolution of a genetic disease in an ethnic isolate: beta-thalassemia in the Jews of Kurdistan. Proc Natl Acad Sci USA. 1991;88(1):310–314.
   PubMed Web of Science ®Google Scholar
• De Sanctis V, Kattamis C, Canatan D, et al. β-Thalassemia distribution in the old world: an ancient disease seen from a historical standpoint. Mediterr J Hematol Infect Dis. 2017;9(1):e2017018.
   PubMed Web of Science ®Google Scholar
• Hamamy H, Al-Allawi NAS. Epidemiological profile of common haemoglobinopathies in Arab countries. J Community Genet. 2013;4(2):147–167.
   PubMedGoogle Scholar
• Al-Allawi NAS, Jalal SD, Mohammad AM, et al. β -thalassemia intermedia in Northern Iraq: a single center experience. Biomed Res Int. 2014;2014:262853.
   PubMed Web of Science ®Google Scholar
• Shamoon RP, Al-Allawi NAS, Cappellini MD, et al. Molecular basis of β-thalassemia intermedia in Erbil Province of Iraqi Kurdistan. Hemoglobin. 2015;39(3):178–183.
   PubMed Web of Science ®Google Scholar
• Al-Allawi NAS, Puehringer H, Raheem RA, et al. Genetic modifiers in β-thalassemia intermedia: a study on 102 Iraqi Arab patients. Genet Test Mol Biomarkers. 2015;19(5):242–247.
   PubMed Web of Science ®Google Scholar
• Encyclopedia Britannica. Yazidis [cited 2020 Mar 27]. Available from: http://www.britannica.com/topic/Yazidi.
   Google Scholar
• Angastiniotis M, Eleftheriou A, Galanello R, et al. Prevention of thalassaemias and other haemoglobin disorders. Vol 1: principle. 2nd ed. Nicosia (Cyprus): Thalassaemia International Federation; 2013.
   Google Scholar